| Wnt signaling and drug resistance in cancer Z Zhong, DM Virshup Molecular pharmacology 97 (2), 72-89, 2020 | 184 | 2020 |
| Wnts and the hallmarks of cancer Z Zhong, J Yu, DM Virshup, B Madan Cancer and Metastasis Reviews 39 (3), 625-645, 2020 | 67 | 2020 |
| PORCN inhibition synergizes with PI3K/mTOR inhibition in Wnt-addicted cancers Z Zhong, S Sepramaniam, XH Chew, K Wood, MA Lee, B Madan, ... Oncogene 38 (40), 6662-6677, 2019 | 63 | 2019 |
| Wnt-regulated lncRNA discovery enhanced by in vivo identification and CRISPRi functional validation S Liu, N Harmston, TL Glaser, Y Wong, Z Zhong, B Madan, DM Virshup, ... Genome Medicine 12, 1-22, 2020 | 16 | 2020 |
| A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models Z Zhong, N Harmston, KC Wood, B Madan, DM Virshup The Journal of Clinical Investigation 132 (12), 2022 | 15 | 2022 |
| Abstract LT10: Recurrent FBXW7 Mutations Bypass Wnt/β-catenin Addiction in Cancer Z Zhong, D Virshup Cancer Research 84 (8_Supplement), LT10-LT10, 2024 | | 2024 |
| Recurrent mutations in tumor suppressor FBXW7 bypass Wnt/β-catenin addiction in cancer Z Zhong, DM Virshup Science Advances 10 (14), eadk1031, 2024 | | 2024 |
| Recurrent FBXW7 mutations bypass Wnt/β-catenin addiction in cancer Z Zhong, DM Virshup bioRxiv, 2023.07. 28.550933, 2023 | | 2023 |
